tiprankstipranks

CARTERA - New Portfolio

Rodrigo

CARTERA
Individual Investor
Ranked #128,102 out of 858,889 TipRanks' Investors
Success Rate
66%
117 out of 177
profitable transactions
Average Return
19.46%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▲ 4.15%
6-Month Return▲ 37.18%
12-Month Return-
YTD Return▲ 14.45%
Total Return▲ 93.12%

Best Trade

Opened at
Closed at
Gain▲ 245.32%

Bio

Performance

16.69%0-16.69%
▲ 12.88%
▲ 3.56%
▲ 16.69%
Sep 2025
▲ 10.96%
▲ 2.38%
▲ 5.99%
Oct 2025
▼ 3.68%
▲ 0.19%
▲ 15.66%
Nov 2025
▼ 0.10%
▲ 0.08%
▲ 0.72%
Dec 2025
▲ 4.06%
▲ 1.47%
▲ 5.65%
Jan 2026
▼ 1.12%
▼ 0.86%
▲ 2.34%
Feb 2026
▲ 0.60%
▼ 4.94%
▲ 0.69%
Mar 2026
▲ 4.89%
▲ 4.48%
▲ 5.13%
Apr 2026
TipRanks AverageS&P 500Investor Portfolio
▲ 12.88%▲ 3.56%▲ 16.69%
▲ 10.96%▲ 2.38%▲ 5.99%
▼ 3.68%▲ 0.19%▲ 15.66%
▼ 0.10%▲ 0.08%▲ 0.72%
▲ 4.06%▲ 1.47%▲ 5.65%
▼ 1.12%▼ 0.86%▲ 2.34%
▲ 0.60%▼ 4.94%▲ 0.69%
▲ 4.89%▲ 4.48%▲ 5.13%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Solaris Energy Infrastructure
5.8%
▲ 39.38%
11
Buy
Apr 02, 2026
Micron
2.84%
▲ 26.50%
3
Open
Apr 02, 2026
Fair Isaac
▼ 28.34%
2
Close
Apr 02, 2026
Viridian Therapeutics
2.89%
▼ 31.85%
3
Buy
Apr 02, 2026
Aldeyra Therapeutics
▼ 65.91%
2
Close
Apr 02, 2026
Babcock & Wilcox Company
3.88%
▲ 61.53%
5
Buy
Apr 02, 2026
ALX Oncology Holdings
2.07%
▼ 13.71%
1
Open
Apr 02, 2026
ImmunityBio
2.3%
▲ 9.31%
1
Open
Mar 30, 2026
Tyra Bioscience
4.47%
▲ 37.21%
6
Buy
Mar 24, 2026
CytomX Therapeutics
1.93%
▲ 8.18%
4
Buy
Mar 19, 2026
Dave
▲ 3.15%
2
Close
Mar 17, 2026
Dianthus Therapeutics
4.34%
▲ 46.36%
5
Buy
Mar 13, 2026
Allogene Therapeutics
5%
▲ 52.94%
3
Buy
Mar 13, 2026
Microsoft
2.12%
▼ 4.23%
9
Open
Mar 06, 2026
Tango Therapeutics
3.74%
▲ 146.07%
4
Sell
Mar 06, 2026
Natural Gas Services Group
▲ 12.55%
2
Buy
Mar 06, 2026
Ocular Therapeutix
2.44%
▼ 7.71%
2
Buy
Mar 06, 2026
nCino
2.46%
▲ 3.75%
1
Open
Mar 06, 2026
Disc Medicine
▲ 4.41%
2
Close
Mar 04, 2026
Advanced Micro Devices
5.78%
▲ 24.37%
3
Buy
Mar 02, 2026